XML 52 R39.htm IDEA: XBRL DOCUMENT v3.22.0.1
INTANGIBLE ASSETS AND GOODWILL (Tables)
12 Months Ended
Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of net-book value and estimated remaining life and finite lived intangible assets
The following table summarizes the net-book-value and estimated remaining life of the Company's intangible assets as of December 31, 2021:
(In thousands)Weighted Average Remaining Life (Years)CostAccumulated AmortizationNet Balance at December 31, 2021
Finite-lived intangible assets
Trade name13.4$104,700 $(13,554)$91,146 
Customer relationships9.66,700 (1,577)5,123 
Patents and licenses3.610,942 (6,763)4,178 
Supply agreement5.42,295 (101)2,194 
Acquired developed technology8.6918,171 (176,402)741,769 
Total finite-lived intangible assets1,042,808 (198,397)844,411 
In-process research and developmentn/a1,250,000 — 1,250,000 
Total intangible assets$2,292,808 $(198,397)$2,094,411 
The following table summarizes the net-book-value and estimated remaining life of the Company’s intangible assets as of December 31, 2020:
(In thousands)Weighted Average Remaining Life (Years)CostAccumulated AmortizationNet Balance at December 31, 2020
Finite-lived intangible assets
Trade name14.9$100,700 $(7,258)$93,442 
Customer relationships12.82,700 (404)2,296 
Patents3.710,441 (5,422)5,019 
Supply agreement6.530,000 (4,527)25,473 
Acquired developed technology9.0814,171 (93,278)720,893 
Total intangible assets$958,012 $(110,889)$847,123 
Schedule of estimated future amortization expense, intangible assets
As of December 31, 2021, the estimated future amortization expense associated with the Company’s finite-lived intangible assets for each of the five succeeding fiscal years is as follows:
(In thousands)
2022$98,614 
202398,611 
202498,277 
202597,230 
202696,169 
Thereafter355,510 
$844,411 
Schedule of carrying amount of goodwill
The change in the carrying amount of goodwill for the years ended December 31, 2021 and 2020 is as follows:
(In thousands)
Balance, January 1, 2020 (1)$1,203,197 
Paradigm & Viomics acquisition30,431 
Genomic Health acquisition adjustment (2)
4,044 
Balance, December 31, 20201,237,672 
Thrive acquisition948,105 
Ashion acquisition56,758 
PreventionGenetics acquisition92,637 
Balance, December 31, 2021$2,335,172 
_________________________________
(1) The beginning balance represents the goodwill acquired from the acquisitions of Sampleminded, Inc., Biomatrica, Inc., and Genomic Health between 2017 and 2019 totaling $2.0 million, $15.3 million, and $1.19 billion, respectively.
(2) The Company recognized a measurement period adjustment to goodwill related to an increase in Genomic Health's pre-acquisition deferred tax liability due to finalization of certain income-tax related items.